Resveratrol inhibits the growth of gastric cancer via the wnt/β-catenin pathway

50Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

Abstract

The inhibitory effect of resveratrol on the growth of gastric cancer cells through downregulation of the Wnt/β-catenin signaling pathway were studied. First we determined the effective concentration of resveratrol on the growth and proliferation of MGC-803 gastric cancer cells. Methylthiazolyl tetrazolium assay showed that resveratrol significantly inhibited the proliferation of MGC-803 cells in a dose-dependent manner. Resveratrol induced apoptotic morphological changes in MGC-803 cells. Reverse transcription-polymerase chain reaction and western blot analysis showed that resveratrol downregulated the expression of three important components of the Wnt signaling pathway, β-catenin, c-myc, and cyclin D1, at the mRNA and protein levels. Overall, resveratrol inhibits the growth of MGC-803 cells by inhibiting the Wnt signaling pathway. This study provides a new idea and direction for the antitumor mechanism of resveratrol.

Cite

CITATION STYLE

APA

Dai, H., Deng, H. B., Wang, Y. H., & Guo, J. J. (2018). Resveratrol inhibits the growth of gastric cancer via the wnt/β-catenin pathway. Oncology Letters, 16(2), 1579–1583. https://doi.org/10.3892/ol.2018.8772

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free